Recent Finacing
Recent Raise
Sitari Pharmaceuticals is a San Diego-based biotech developing TG2-targeted therapies for celiac disease and other indications using Stanford-licensed IP, with Avalon-led operational management and COI Pharma R&D support.
Focus Areas
Total Raised
Funding round